326 related articles for article (PubMed ID: 16573774)
1. Reports of "satisfactory relief" by IBS patients receiving usual medical care are confounded by baseline symptom severity and do not accurately reflect symptom improvement.
Whitehead WE; Palsson OS; Levy RL; Feld AD; VonKorff M; Turner M
Am J Gastroenterol; 2006 May; 101(5):1057-65. PubMed ID: 16573774
[TBL] [Abstract][Full Text] [Related]
2. Measuring successful treatment of irritable bowel syndrome: is "satisfactory relief " enough?
Schoenfeld P; Talley NJ
Am J Gastroenterol; 2006 May; 101(5):1066-8. PubMed ID: 16696786
[TBL] [Abstract][Full Text] [Related]
3. Is there a difference between abdominal pain and discomfort in moderate to severe IBS patients?
Sach J; Bolus R; Fitzgerald L; Naliboff BD; Chang L; Mayer EA
Am J Gastroenterol; 2002 Dec; 97(12):3131-8. PubMed ID: 12492200
[TBL] [Abstract][Full Text] [Related]
4. Health-related quality of life, work productivity, and health care resource utilization of subjects with irritable bowel syndrome: baseline results from LOGIC (Longitudinal Outcomes Study of Gastrointestinal Symptoms in Canada), a naturalistic study.
Paré P; Gray J; Lam S; Balshaw R; Khorasheh S; Barbeau M; Kelly S; McBurney CR
Clin Ther; 2006 Oct; 28(10):1726-35; discussion 1710-1. PubMed ID: 17157129
[TBL] [Abstract][Full Text] [Related]
5. Irritable bowel syndrome in France: quality of life, medical management, and costs: the Encoli study.
Brun-Strang C; Dapoigny M; Lafuma A; Wainsten JP; Fagnani F
Eur J Gastroenterol Hepatol; 2007 Dec; 19(12):1097-103. PubMed ID: 17998835
[TBL] [Abstract][Full Text] [Related]
6. Functional bowel disorders in primary care: factors associated with health-related quality of life and doctor consultation.
Lee V; Guthrie E; Robinson A; Kennedy A; Tomenson B; Rogers A; Thompson D
J Psychosom Res; 2008 Feb; 64(2):129-38. PubMed ID: 18222126
[TBL] [Abstract][Full Text] [Related]
7. Gastrointestinal-specific anxiety: an important factor for severity of GI symptoms and quality of life in IBS.
Jerndal P; Ringström G; Agerforz P; Karpefors M; Akkermans LM; Bayati A; Simrén M
Neurogastroenterol Motil; 2010 Jun; 22(6):646-e179. PubMed ID: 20367800
[TBL] [Abstract][Full Text] [Related]
8. A randomized controlled trial of cognitive behavior therapy, relaxation training, and routine clinical care for the irritable bowel syndrome.
Boyce PM; Talley NJ; Balaam B; Koloski NA; Truman G
Am J Gastroenterol; 2003 Oct; 98(10):2209-18. PubMed ID: 14572570
[TBL] [Abstract][Full Text] [Related]
9. Tegaserod for female patients suffering from IBS with mixed bowel habits or constipation: a randomized controlled trial.
Chey WD; Paré P; Viegas A; Ligozio G; Shetzline MA
Am J Gastroenterol; 2008 May; 103(5):1217-25. PubMed ID: 18477346
[TBL] [Abstract][Full Text] [Related]
10. Treatment of irritable bowel syndrome with osteopathy: results of a randomized controlled pilot study.
Hundscheid HW; Pepels MJ; Engels LG; Loffeld RJ
J Gastroenterol Hepatol; 2007 Sep; 22(9):1394-8. PubMed ID: 17716344
[TBL] [Abstract][Full Text] [Related]
11. Coping strategies and interpersonal support in patients with irritable bowel syndrome and inflammatory bowel disease.
Jones MP; Wessinger S; Crowell MD
Clin Gastroenterol Hepatol; 2006 Apr; 4(4):474-81. PubMed ID: 16616353
[TBL] [Abstract][Full Text] [Related]
12. [Comparative analysis of efficiency of the estimation of quality of life in patients with irritable bowel syndrome using questionnaires IBS-QOL and index BEST].
Pilipenko VI; Isakov VA
Eksp Klin Gastroenterol; 2008; (6):4-8. PubMed ID: 19334419
[TBL] [Abstract][Full Text] [Related]
13. A randomized, double-blind, placebo-controlled study to assess efficacy and safety of 0.5 mg and 1 mg alosetron in women with severe diarrhea-predominant IBS.
Krause R; Ameen V; Gordon SH; West M; Heath AT; Perschy T; Carter EG
Am J Gastroenterol; 2007 Aug; 102(8):1709-19. PubMed ID: 17509028
[TBL] [Abstract][Full Text] [Related]
14. Quality of life in patients with inflammatory bowel disease and irritable bowel syndrome differs between subjects recruited from clinic or the internet.
Jones MP; Bratten J; Keefer L
Am J Gastroenterol; 2007 Oct; 102(10):2232-7. PubMed ID: 17680842
[TBL] [Abstract][Full Text] [Related]
15. Food-specific IgG4 antibody-guided exclusion diet improves symptoms and rectal compliance in irritable bowel syndrome.
Zar S; Mincher L; Benson MJ; Kumar D
Scand J Gastroenterol; 2005 Jul; 40(7):800-7. PubMed ID: 16109655
[TBL] [Abstract][Full Text] [Related]
16. The usual medical care for irritable bowel syndrome.
Whitehead WE; Levy RL; Von Korff M; Feld AD; Palsson OS; Turner M; Drossman DA
Aliment Pharmacol Ther; 2004 Dec; 20(11-12):1305-15. PubMed ID: 15606392
[TBL] [Abstract][Full Text] [Related]
17. Definition and classification of irritable bowel syndrome: current consensus and controversies.
Longstreth GF
Gastroenterol Clin North Am; 2005 Jun; 34(2):173-87. PubMed ID: 15862928
[TBL] [Abstract][Full Text] [Related]
18. Clinical determinants of health-related quality of life in patients with irritable bowel syndrome.
Spiegel BM; Gralnek IM; Bolus R; Chang L; Dulai GS; Mayer EA; Naliboff B
Arch Intern Med; 2004 Sep; 164(16):1773-80. PubMed ID: 15364671
[TBL] [Abstract][Full Text] [Related]
19. Symptom severity but not psychopathology predicts visceral hypersensitivity in irritable bowel syndrome.
van der Veek PP; Van Rood YR; Masclee AA
Clin Gastroenterol Hepatol; 2008 Mar; 6(3):321-8. PubMed ID: 18258487
[TBL] [Abstract][Full Text] [Related]
20. A comparison of irritable bowel syndrome patients managed in primary and secondary care: the Episode IBS study.
Smith GD; Steinke DT; Kinnear M; Penny KI; Pathmanathan N; Penman ID;
Br J Gen Pract; 2004 Jul; 54(504):503-7. PubMed ID: 15239911
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
